Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema
Matthew M Wessel, Nandini Nair, Grant D Aaker, Joshua R Ehrlich, Donald J D'Amico, Szilárd Kiss, Matthew M Wessel, Nandini Nair, Grant D Aaker, Joshua R Ehrlich, Donald J D'Amico, Szilárd Kiss
Abstract
Purpose: To determine the relationship between retinal ischaemia and the presence of macular oedema (DMO) in patients with diabetic retinopathy (DR) using ultra-widefield fluorescein angiography (UWFA) imaging.
Methods: A retrospective review of 122 eyes of 70 treatment-naïve diabetic patients who underwent diagnostic UWFA using the Optos 200Tx imaging system. Two independent, masked graders quantified the area of retinal ischaemia. Based on clinical examination and optical coherence tomography (OCT), each patient was given a binary classification as either having DMO or no DMO. McNemar's test (with Yates' correction as indicated) and a two-sample test of proportions were used to determine the relationship between DMO and ischaemia for binary and proportional data, respectively. Linear and logistic models were constructed using generalised estimating equations to test relationships between independent variables, covariates and outcomes while controlling for inter-eye correlation, age, gender, haemoglobin A1c, mean arterial pressure and dependence on insulin.
Results: Seventy-six eyes (62%) exhibited areas of retinal ischaemia. There was a significant direct correlation between DMO and peripheral retinal ischaemia as seen on UWFA (p<0.001). In addition, patients with retinal ischaemia had 3.75 times increased odds of having DMO compared with those without retinal ischaemia (CI 1.26 to 11.13, p<0.02).
Conclusion: Retinal ischaemia is significantly correlated with DMO in treatment-naïve patients with DR. UWFA is a useful tool for detecting peripheral retinal ischaemia, which may have direct implications in the diagnosis, follow-up and treatment such as targeted peripheral photocoagulation.
Conflict of interest statement
Competing interests: SK serves as a consultation to Optos, PLC. No additional competing interests declared.
Figures
References
- World Health Organization Global Initiative for the Elimination of Avoidable Blindness: Action Plan 2006–2011. Geneva, Switzerland: World Health Organization, 2007
- Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134–9
- Photocoagulation for Diabetic Macular Edema Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group. Arch Ophthalmol 1985;103:1796–806
- Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–7
- Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445–50
- Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999–1005
- Schwartz SD, Gupta A, Gonzales CR, et al. Peripheral retinal ischemia associated with diffuse diabetic macular edema identified with widefield angiography. Invest Ophthalmol Vis Sci 2005;46:ARVO E-Abstract 4793.
- Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema in patients with optical coherence tomography. Am J Ophthalmol 1999;127:688–93
- Friberg TR, Forrester JV. Ultrawide angle (200°+) fluorescein angiography using a modified Optos Panoramic200TM Imaging System. Invest Ophthalmol Vis Sci 2004;45:ARVO E-Abstract 3001.
- Friberg TR, Gupta A, Yu J, et al. Ultrawide angle fluorescein angiographic imaging: a comparison to conventional digital acquisition systems. Ophthalmic Surg Lasers Imaging 2008;39:304–11
- Csutak A, Lengyel I, Jonasson F, et al. Agreement between image grading of conventional (45 degrees) and ultra wide-angle (200 degrees) digital images in the macula in the Reykjavik eye study. Eye (Lond) 2010;24:1568–75
- Mackenzie PJ, Russell M, Ma PE, et al. Sensitivity and specificity of the optos optomap for detecting peripheral retinal lesions. Retina 2007;27:1119–24
- Wessel MM, Aaker GD, Parlitsis G, et al. Ultra-widefield angiography significantly Improves the detection and classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 2010;51:ARVO E-Abstract 4689.
- Kook D, Wolf A, Kreutzer T, et al. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina 2008;28:1053–60
- Arevalo JF, Sanchez JG, Fromow-Guerra J, et al. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol 2009;247:735–43
- Michaelides M, Kaines A, Hamilton RD, et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 2010;117:1078–86.e2
- Oliver SCN, Schwartz SD. Ultra-widefield fluorescein angiography. In: Fernando Arevalo J, ed. Retinal Angiography and Optical Coherence Tomography. New York: Springer Science and Business Media, LLC, 2009:407–17
Source: PubMed